BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1946543)

  • 21. Cell proliferation in carcinogenesis.
    Cohen SM; Ellwein LB
    Science; 1990 Aug; 249(4972):1007-11. PubMed ID: 2204108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell proliferation and promotion in the hepatocarcinogenicity of peroxisome proliferating chemicals.
    Cattley RC; Marsman DS; Popp JA
    Prog Clin Biol Res; 1990; 340D():123-32. PubMed ID: 2196574
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity of hepatocytes to the effect of factors stimulating and suppressing cell proliferation in hepatocarcinogenesis].
    Osipova LA
    Eksp Onkol; 1984; 6(2):23-6. PubMed ID: 6510330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genesis of cancer with chemicals.
    Farber E
    Arch Pathol Lab Med; 1980 Oct; 104(10):499-502. PubMed ID: 6893394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemically induced cell proliferation as a predictive assay for potential carcinogenicity.
    Butterworth BE
    Prog Clin Biol Res; 1991; 369():457-67. PubMed ID: 1946540
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture.
    Farber E
    Cancer Res; 1984 Dec; 44(12 Pt 1):5463-74. PubMed ID: 6388826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferation and hepatocarcinogenesis.
    Reddy JK; Rao MS
    IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
    [No Abstract]   [Full Text] [Related]  

  • 31. Epigenetic mechanisms of liver tumor promotion.
    Williams GM
    Prog Clin Biol Res; 1990; 331():131-45; discussion 147-8. PubMed ID: 2179956
    [No Abstract]   [Full Text] [Related]  

  • 32. Dietary modulation of the carcinogenicity of the heterocyclic amines.
    Weisburger JH; Rivenson A; Kingston DG; Wilkins TD; Van Tassell RL; Nagao M; Sugimura T; Hara Y
    Princess Takamatsu Symp; 1995; 23():240-50. PubMed ID: 8844815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.
    Yano BL; Hardisty JF; Seely JC; Butterworth BE; McConnell EE; Swenberg JA; Williams GM; Stebbins KE; Golllapudi BB; Eisenbrandt DL
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):53-65. PubMed ID: 18367300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of adaptation to phenobarbital may cause selective growth of foci of altered cells in rat liver.
    Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
    IARC Sci Publ; 1984; (56):67-75. PubMed ID: 6152623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of liver and peripheral blood micronucleus assays with nine chemicals using young rats.
    Zeiger E
    Mutat Res; 2005 Nov; 587(1-2):152; author reply 153. PubMed ID: 16185911
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment.
    Croy RG
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):289-302. PubMed ID: 8013422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the form of the cell growth rate function of the two-stage model for carcinogenesis.
    Charnley G; Wilson JD
    Prog Clin Biol Res; 1991; 369():291-301. PubMed ID: 1946526
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell proliferation and carcinogenesis.
    Cohen SM
    Drug Metab Rev; 1998 May; 30(2):339-57. PubMed ID: 9606608
    [No Abstract]   [Full Text] [Related]  

  • 40. An alternative perspective: a critical evaluation of the Waddell threshold extrapolation model in chemical carcinogenesis.
    Haseman JK
    Toxicol Pathol; 2003; 31(5):468-70. PubMed ID: 14692613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.